Medicaments for treating respiratory disorders
Patent 5688782 Issued on November 18, 1997. Estimated Expiration Date: 
June 2, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
June 2, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesProcess for the preparation of a mixture of an anti-inflammatory steroid and a fluoro-chloro-hydrocarbon to be used as a propellant Physically modified beclomethasone dipropionate suitable for use in aerosols Micronised beclomethasone dipropionate monohydrate compositions and methods of use Patent #: 4866051 InventorsAssigneeApplicationNo. 458241 filed on 06/02/1995US Classes:514/180, 9-position substituted424/45Organic pressurized fluidExaminersPrimary: Cintins, Marianne M.Assistant: Jones, Dwayne C. Attorney, Agent or FirmForeign Patent References
International ClassesA61K 031/56A61L 009/04 Foreign Application Priority Data1992-02-06 GBAbstractThis invention relates to aerosol formulations of use for the administration of medicaments by inhalation, in particular a pharmaceutical aerosol formulation which comprises: (a) beclomethasone dipropionate monohydrate, the particle size of substantially all the monohydrate being less than 20 microns; (b) at least 0.015% by weight of the formulation of water in addition to the water of crystallization associated with the monohydrate; and (c) a fluorocarbon or hydrogen-containing chlorofluorocarbon propellant. A method of treating respiratory disorders which comprises administration by inhalation of an effective amount of a pharmaceutical aerosol formulation as defined is also described. | |
